Tech Update

Biotronik Launches Cardiac Remote Monitoring in India

The system is available across the entire product portfolio of pacemakers, ICDs and Cardiac Resynchronisation Therapy (CRT) devices

From left to right: Prof KK Sethi, Prof Pedro Brugada, and Gunnar Wochnowski

After the launch of Biotronik Home Monitoring Enabled Implantable Cardiac Devices last year, Biotronik Medical Devices India Private Limited, a subsidiary of Biotronik GmbH & Co KG Germany, a manufacturer of implantable cardiac devices, and pioneer in wireless remote monitoring technology, announced the India launch of the Biotronik Innovation Forum & New Home Monitoring services, recently. The required approval has been obtained from DoT.

A pioneer in cardiology and inventor of Brugada Syndrome, Prof Pedro Brugada, launched the Biotronik Home Monitoring Service and Biotronik Innovation Forum. "The new Biotronik Home Monitoring system is based on more than eight years of experience in remote monitoring technology and extensive research among both physicians and patients. The system is available across the entire product portfolio of pacemakers, ICDs and cardiac resynchronisation therapy (CRT) devices allowing physicians to remotely monitor their patients' clinical and device status at any time and from anywhere in the world," said Gunnar Wochnowski, Vice President, Biotronik - Asia Pacific.

"Biotronik has set a milestone with the launch of its new home monitoring system-an advanced, evidence-based remote monitoring technology, with early detection of arrhythmias and other clinically relevant events, delivering simplified yet safe and efficient patient care," said Prof (Dr) Pedro Brugada, Head, Heart Rhythm Management Institute, Cardiology Department, Free University of Brussels, Belgium. He further added, "This is a quantum leap in cardiac arrhythmia therapy as well, therefore this technology acts as a boon for pacemaker and ICD patients with a continuous, automatic monitoring of the patient's cardiac status." Earlier patients had to physically be present for checking the status of the patient's heart and pacemaker. Patients with pacemakers, defibrillators and other implanted cardiac devices require regular, scheduled hospital visits to monitor whether the implanted devices are working optimally. Many patients require additional non-scheduled visits to investigate symptoms that may or may not relate to their cardiac disease or device.

The potential clinical advantages of remote monitoring include timelier monitoring and treatment of patient symptoms and events, with a potential reduction in in-patient hospital stays related to cardiac events. Its also includes reduction in routine patient follow-up, closer monitoring of device longevity that may extend usage, and reduced patient transport costs. This is also a good tool to diagnose non symptomatic cardiac diseases as and when it occurs, this early detection can be handy for physicians for better patient's diseases management.

Using an intuitive, red-yellow-coded traffic light concept, Biotronik Home Monitoring quickly and easily identifies patients with the most clinically relevant events to streamline clinic workflow; ensuring efficient use of clinic time by reducing unnecessary in-office follow-ups and so improving patient care. Daily as well as trend patient and device information is automatically evaluated and prioritised through the intelligent traffic light system and conveniently presented in the CardioReport.

Furthermore, the advanced functionality of Biotronik Home Monitoring and its intelligent workflow tools facilitate the establishment of unique collaborative care networks, allowing multiple clinics and physicians to simultaneously manage an individual patient.

EH News Bureau